These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3258181)

  • 41. Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.
    Sharkey RM; Primus FJ; Shochat D; Goldenberg DM
    Cancer Res; 1988 Apr; 48(7):1823-8. PubMed ID: 3349460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Altered metabolism of carcinoembryonic antigen in hamsters bearing GW-39 tumours.
    Primus FJ; Hansen HJ; Goldenberg DM
    Nature; 1974 Jun; 249(460):837-8. PubMed ID: 4834788
    [No Abstract]   [Full Text] [Related]  

  • 43. A human colon cancer metastasis model for radioimmunodetection.
    Sharkey RM; Filion D; Fand I; Primus FJ; Goldenberg DM
    Cancer Res; 1986 Jul; 46(7):3677-83. PubMed ID: 3518921
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Retention of human properties by a xenografted human colonic tumor, GW-77, propagated in unconditioned hamsters.
    Goldenberg DM; Bhan RD; Pavia RA
    Proc Soc Exp Biol Med; 1970 Dec; 135(3):657-9. PubMed ID: 4922352
    [No Abstract]   [Full Text] [Related]  

  • 45. Synergistic effects of x-rays and drugs on a human tumor xenograft, GW-39.
    Goldenberg DM; Ammersdörfer E
    Eur J Cancer (1965); 1970 Apr; 6(2):73-80. PubMed ID: 5450200
    [No Abstract]   [Full Text] [Related]  

  • 46. Propionamide participating in H
    Zhao X; Li Y; Zuo C; Sun Y; Xu F; Nadykto AB; Du L; Xu Y; Zhang Q; Wang W
    RSC Adv; 2020 Dec; 11(1):493-500. PubMed ID: 35423025
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hematopoiesiesis in the spleen of tumor-bearing hamsters.
    KELSALL MA
    J Natl Cancer Inst; 1949 Dec; 10(3):625-35. PubMed ID: 15403015
    [No Abstract]   [Full Text] [Related]  

  • 48. Second antibody for improvement of antibody imaging: liposome-entrapped and free preparations in animal and human studies.
    Begent HJ; Chester KA; Bagshawe KD; Keep PA; Searle F; Boden J; Barratt GM; Green AJ; Riggs SJ; Woodrow DF
    Clin Exp Immunol; 1989 Nov; 78(2):307-13. PubMed ID: 12412766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
    Marshall D; Pedley RB; Boden JA; Boden R; Melton RG; Begent RH
    Br J Cancer; 1996 Mar; 73(5):565-72. PubMed ID: 8605088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
    Marshall D; Pedley RB; Boden JA; Boden R; Begent RH
    Br J Cancer; 1994 Mar; 69(3):502-7. PubMed ID: 8123481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The fate of antibodies and their radiolabels bound to tumor cells in vitro: the effect of cross-linking at the cell surface and of anti-idiotype antibodies.
    Ong GL; Marria V; Mattes MJ
    Cancer Immunol Immunother; 1994 Nov; 39(5):325-31. PubMed ID: 7987864
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of clearance of plant lectins as radiopharmaceuticals by chemically glycosylated antilectin antibody.
    Kojima S; Imagawa M; Gabius HJ
    Eur J Nucl Med; 1989; 15(7):373-5. PubMed ID: 2776797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid background reduction of circulating sodium iodide I 125-labelled Pisum sativum agglutinin used as a tumor-imaging radiopharmaceutical by the chemically galactosylated antibody.
    Kojima S; Kubota K; Kubodera A; Imagawa M; Gabius HJ
    Eur J Nucl Med; 1990; 16(11):781-6. PubMed ID: 2209646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment.
    Ford CH; Richardson VJ; Reddy VS
    Indian J Pediatr; 1990; 57(1):29-46. PubMed ID: 2193879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors influencing anti-antibody enhancement of tumor targeting with antibodies in hamsters with human colonic tumor xenografts.
    Sharkey RM; Mabus J; Goldenberg DM
    Cancer Res; 1988 Apr; 48(8):2005-9. PubMed ID: 3258181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies.
    Goldenberg DM; Sharkey RM; Ford E
    J Nucl Med; 1987 Oct; 28(10):1604-10. PubMed ID: 3498807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing bispecific antibody pretargeting for use in radioimmunotherapy.
    Sharkey RM; Karacay H; Richel H; McBride WJ; Rossi EA; Chang K; Yeldell D; Griffiths GL; Hansen HJ; Goldenberg DM
    Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3897S-913S. PubMed ID: 14506188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental radioimmunotherapy of a xenografted human colonic tumor (GW-39) producing carcinoembryonic antigen.
    Goldenberg DM; Gaffar SA; Bennett SJ; Beach JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4354-60. PubMed ID: 7306964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biological considerations for radioimmunotherapy.
    Sharkey RM; Blumenthal RD; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):964s-969s. PubMed ID: 2297750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.
    Sharkey RM; Pykett MJ; Siegel JA; Alger EA; Primus FJ; Goldenberg DM
    Cancer Res; 1987 Nov; 47(21):5672-7. PubMed ID: 3664474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.